Related Experiment Video

Updated: Jun 6, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Involvement of the PLCε/PKCα pathway in human BIU-87 bladder cancer cell proliferation

Yan Ling1, Luo Chunli, Wu Xiaohou

  • 1Department of Laboratory Medical Diagnostics, Chongqing Medical University, Peoples Republic of China.

Cell Biology International
|December 3, 2010
PubMed

Insights

Phospholipase Cε (PLCε) is crucial in bladder cancer. Silencing PLCε inhibits cancer cell proliferation and down-regulates key oncogenes, suggesting PLCε as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Phospholipase Cε (PLCε), a small GTPase effector, is implicated in carcinogenesis.
  • Its specific role in bladder cancer remains underexplored.
  • Previous research indicated high PLCε mRNA expression in bladder cancer tissues.

Purpose of the Study:

  • To investigate the bio-function of PLCε in bladder cancer.
  • To determine the effect of PLCε gene silencing on bladder cancer cell characteristics.
  • To elucidate the molecular mechanisms underlying PLCε's role in bladder cancer proliferation.

Main Methods:

  • Silencing of the PLCε gene using small-hairpin RNA (shRNA) in the BIU-87 bladder cancer cell line.
  • Assessment of cell proliferation and cell cycle progression.
  • Analysis of protein kinase Cα (PKCα) activity.
  • Evaluation of oncogene expression, including c-fos and c-jun.

Main Results:

  • PLCε gene silencing significantly inhibited bladder cancer cell proliferation.
  • Cell cycle arrest at the G0/G1 phase was observed following PLCε knockdown.
  • Down-regulation of oncogenes c-fos and c-jun was associated with reduced PLCε expression.
  • PLCε's regulatory role in bladder cancer cell characteristics was linked to PKCα activity.

Conclusions:

  • PLCε plays a critical role in bladder cancer progression and proliferation.
  • PLCε may serve as a key regulatory molecule in bladder cancer signaling pathways.
  • Targeting PLCε presents a potential therapeutic strategy for bladder cancer treatment.

More Related Videos

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...